InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Shemesh Shay. Insider active across 1 companies, notably Nuvectis Pharma, Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €19k. The latest transaction was disclosed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€4,690300 shares@ €15.63480.0016% mcap24.1% of flow
Common Stock
SEC:0001104659-22-063644:0·
Ideal exit: 14 Feb 2023 (T+270)
€1,847100 shares@ €18.46930.0006% mcap9.5% of flow
Common Stock
SEC:0001104659-22-062271:0·
Ideal exit: 10 Feb 2023 (T+270)
€50636 shares@ €14.04680.0002% mcap2.6% of flow
Common Stock
SEC:0001104659-22-059890:0·
Ideal exit: 6 Feb 2023 (T+270)
060,000 shares0
Common Stock
SEC:0001104659-22-042814:0·
€6,2072,100 shares@ €2.95560.0021% mcap31.9% of flow
Common Stock, par value $0.00001
SEC:0001104659-22-014375:0·
Ideal exit: 1 Nov 2022 (T+270)
€6,2072,100 shares@ €2.9556100.0% of flow
Common Stock, par value $0.00001
SEC:0001104659-22-014375·
Ideal exit: 1 Nov 2022 (T+270)
6 of 6 declarations
About Shemesh Shay
Shemesh Shay is a director at Nuvectis Pharma, Inc.
